Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

694 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Personalized Antihypertensive Treatment Optimization With Smartphone-Enabled Remote Precision Dosing of Amlodipine During the COVID-19 Pandemic (PERSONAL-CovidBP Trial).
Collier DJ, Taylor M, Godec T, Shiel J, James R, Chowdury Y, Ebano P, Monk V, Patel M, Pheby J, Pheby R, Foubister A, David C, Saxena M, Richardson L, Siddle J, Timlin G, Goldsmith P, Deeming N, Poulter NR, Gabe R, McManus RJ, Caulfield MJ. Collier DJ, et al. Among authors: saxena m. J Am Heart Assoc. 2024 Feb 20;13(4):e030749. doi: 10.1161/JAHA.123.030749. Epub 2024 Feb 7. J Am Heart Assoc. 2024. PMID: 38323513 Free PMC article. Clinical Trial.
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial.
Brown MJ, Williams B, Morant SV, Webb DJ, Caulfield MJ, Cruickshank JK, Ford I, McInnes G, Sever P, Salsbury J, Mackenzie IS, Padmanabhan S, MacDonald TM; British Hypertension Society's Prevention and Treatment of Hypertension with Algorithm-based Therapy (PATHWAY) Studies Group. Brown MJ, et al. Lancet Diabetes Endocrinol. 2016 Feb;4(2):136-47. doi: 10.1016/S2213-8587(15)00377-0. Epub 2015 Oct 18. Lancet Diabetes Endocrinol. 2016. PMID: 26489809 Free PMC article. Clinical Trial.
A Discussion on the Regulation of Blood Flow and Pressure.
Wolff CB, Collier DJ, Shah M, Saxena M, Brier TJ, Kapil V, Green D, Lobo M. Wolff CB, et al. Among authors: saxena m. Adv Exp Med Biol. 2016;876:129-135. doi: 10.1007/978-1-4939-3023-4_16. Adv Exp Med Biol. 2016. PMID: 26782204
Controversies Surrounding Renal Denervation: Lessons Learned From Real-World Experience in Two United Kingdom Centers.
Burchell AE, Chan K, Ratcliffe LE, Hart EC, Saxena M, Collier DJ, Jain AK, Mathur A, Knight CJ, Caulfield MJ, Paton JF, Nightingale AK, Lobo MD, Baumbach A. Burchell AE, et al. Among authors: saxena m. J Clin Hypertens (Greenwich). 2016 Jun;18(6):585-92. doi: 10.1111/jch.12789. Epub 2016 Feb 9. J Clin Hypertens (Greenwich). 2016. PMID: 26857092 Free PMC article. Review.
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
Williams B, MacDonald TM, Morant SV, Webb DJ, Sever P, McInnes GT, Ford I, Cruickshank JK, Caulfield MJ, Padmanabhan S, Mackenzie IS, Salsbury J, Brown MJ; British Hypertension Society programme of Prevention And Treatment of Hypertension With Algorithm based Therapy (PATHWAY) Study Group. Williams B, et al. Lancet Diabetes Endocrinol. 2018 Jun;6(6):464-475. doi: 10.1016/S2213-8587(18)30071-8. Epub 2018 Apr 11. Lancet Diabetes Endocrinol. 2018. PMID: 29655877 Free PMC article.
A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program-AIM-HY INFORM trial.
Mukhtar O, Cheriyan J, Cockcroft JR, Collier D, Coulson JM, Dasgupta I, Faconti L, Glover M, Heagerty AM, Khong TK, Lip GYH, Mander AP, Marchong MN, Martin U, McDonnell BJ, McEniery CM, Padmanabhan S, Saxena M, Sever PJ, Shiel JI, Wych J, Chowienczyk PJ, Wilkinson IB. Mukhtar O, et al. Among authors: saxena m. Am Heart J. 2018 Oct;204:102-108. doi: 10.1016/j.ahj.2018.05.006. Epub 2018 May 20. Am Heart J. 2018. PMID: 30092411 Free PMC article. Clinical Trial.
First-in-man treatment of severe blood pressure variability with baroreflex activation therapy.
Floyd CN, Adeel MY, Wolff CB, Julu P, Shah M, Collier DJ, Saxena M, Brier T, Ng F, Kapil V, Mukhtar O, Radunovic A, Sutcliffe N, Sharif F, O'Brien T, Lobo MD. Floyd CN, et al. Among authors: saxena m. Int J Cardiol. 2016 Oct 1;220:577-9. doi: 10.1016/j.ijcard.2016.06.308. Epub 2016 Jun 29. Int J Cardiol. 2016. PMID: 27390993 No abstract available.
694 results